Editas Medicine

Filed a patent for "systems and methods for the treatment of hemoglobinopathies" on Fri, January 27, 2023

Filed a patent for "systems and methods for the treatment of hemoglobinopathies" on Wed, March 1, 2023

Filed a patent for "systems and methods for the treatment of hemoglobinopathies" on Thu, March 16, 2023

Filed a patent for "methods for treating cep290 associated disease" on Fri, April 21, 2023

Filed a patent for "systems and methods for the treatment of hemoglobinopathies" on Tue, April 25, 2023

Filed a patent for "crispr-related methods and compositions targeting fl1-1 expression" on Fri, May 26, 2023

Filed a patent for "crispr-related methods and compositions targeting cd70 expression" on Fri, May 26, 2023

Filed a patent for "crispr-related methods and compositions targeting ptpn2 expression" on Fri, May 26, 2023

Filed a patent for "systems and methods for the treatment of hemoglobinopathies" on Thu, June 8, 2023

Filed a patent for "systems and methods for the treatment of hemoglobinopathies" on Thu, June 8, 2023

Filed a patent for "systems and methods for the treatment of hemoglobinopathies" on Fri, October 27, 2023

Filed a patent for "systems and methods for the treatment of hemoglobinopathies" on Fri, October 27, 2023

Filed a patent for "systems and methods for the treatment of hemoglobinopathies" on Tue, December 5, 2023

Filed a patent for "systems and methods for the treatment of hemoglobinopathies" on Thu, December 19, 2024

Filed a patent for "crispr/cas-related methods and compositions for treating beta hemoglobinopathies" on Thu, October 31, 2024

Filed a patent for "crispr/cas-related methods and compositions for treating herpes simplex virus type 1 (hsv-1)" on Thu, September 5, 2024

Filed a patent for "novel recombinases and methods of use" on Thu, August 15, 2024

Filed a patent for "crispr/cas-related methods and compositions for improving transplantation" on Thu, August 1, 2024

Filed a patent for "treatment of pain" on Thu, February 15, 2024

Filed a patent for "novel recombinases and methods of use" on Fri, September 16, 2022

Filed a patent for "selection by essential-gene knock-in" on Thu, July 20, 2023

Filed a patent for "engineered cells for therapy" on Wed, November 9, 2022

Filed a patent for "systems and methods for treating alpha 1-antitrypsin (a1at) deficiency" on Thu, April 4, 2024

Filed a patent for "recombinases and methods of use" on Wed, January 18, 2023

Filed a patent for "compositions and methods for treating cep290 associated disease" on Thu, May 2, 2024